IMARC Group’s report titled “Viscosupplementation Market by Type (Single Injection, Three Injection, Five Injection), Age Group (Adults, Geriatrics), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), Application (Knee Osteoarthritis, Hip Osteoarthritis, Hand Osteoarthritis, and Others), End Use (Hospitals, Orthopedic Clinics, and Others), and Region 2024-2032“, The global viscosupplementation market size reached US$ 4.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 8.7 Billion by 2032, exhibiting a growth rate (CAGR) of 7.42% during 2024-2032.
For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/viscosupplementation-market/requestsample
Factors Affecting the Growth of the Viscosupplementation Industry:
- Preferences for Minimally Invasive (MI) Treatments:
Rising preferences for minimally invasive (MI) treatments among patients are impelling the market growth. These treatments involve less trauma to the body, resulting in reduced pain, shorter recovery times, and lower risk of complications as compared to traditional surgical interventions. This aligns with the modern healthcare principles of promoting patient comfort and rapid return to normal activities. Additionally, MI treatments offer outpatient or same-day procedures, minimizing hospital stays and associated costs. This economic benefit appeals to healthcare systems aiming to optimize resource allocation and reduce the financial burden on patients.
- Technological Advancements:
Continuous innovations in viscosupplementation formulations and injection techniques enhance treatment efficacy, safety, and patient outcomes. Newer formulations offer longer-lasting effects and improved bioavailability, addressing previous limitations and expanding the potential patient population. Healthcare providers are more inclined to recommend these advanced treatments, and patients are more receptive to them, which is impelling the market growth. Apart from this, ongoing research and development (R&D) efforts ensure that the field of viscosupplementation remains dynamic and responsive to evolving patient needs and preferences.
- Rising Obesity Rates:
The growing cases of osteoarthritis on account of the increasing obesity problems among the masses around the world are offering a positive market outlook. There is a rise in the demand for effective treatments to alleviate osteoarthritis symptoms, such as joint pain and stiffness. Viscosupplementation injections emerge as an appealing option for obese patients seeking to manage their joint pain and enhance mobility. Due to their weight, obese individuals often experience greater stress on their joints, exacerbating osteoarthritis symptoms. Traditional surgical interventions may carry higher risks and longer recovery times for obese patients. In contrast, viscosupplementation injections offer a less invasive alternative, providing targeted relief by lubricating the affected joints.
Leading Companies Operating in the Global Viscosupplementation Industry:
- Anika Therapeutics Inc.
- Aptissen S.A.
- Bioventus LLC
- Ferring Pharmaceuticals
- Fidia Farmaceutici S.p.A.
- Johnson & Johnson
- LG Chem Ltd.
- OrthogenRx Inc. (Avanos Medical Inc.)
- Sanofi S.A.
- Seikagaku Corporation
- Virchow Biotech Private Limited
- Zimmer Biomet
- Zuventus HealthCare Ltd. (Emcure Pharmaceuticals Limited) etc.
Viscosupplementation Market Report Segmentation:
By Type:
- Single Injection
- Three Injection
- Five Injection
Single injection represents the largest segment due to patient preference for fewer injections.
By Age Group:
- Adults
- Geriatrics
Geriatrics hold the biggest market share, which can be accredited to the rising need for invasive procedures.
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Hospital pharmacies account for the largest market share as they serve as primary centers for the diagnosis and treatment of various medical conditions, including osteoarthritis.
By Application:
- Knee Osteoarthritis
- Hip Osteoarthritis
- Hand Osteoarthritis
- Others
Knee osteoarthritis exhibits a clear dominance in the market on account of the rising need for affected targeted solutions.
By End Use:
- Hospitals
- Orthopedic Clinics
- Others
Orthopedic clinics account for the majority of the market share, driven by the increasing demand for specialized care among individuals.
Regional Insights:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
North America enjoys a leading position in the viscosupplementation market, which can be attributed to the presence of advanced healthcare infrastructure.
Global Viscosupplementation Market Trends:
Favorable reimbursement policies and insurance coverage for viscosupplementation injections make them more accessible and affordable to patients. Expanded coverage programs encourage patient adoption and contribute to market growth. In addition, the increasing focus on maintaining an active lifestyle and participation in physical activities is propelling the market growth. Individuals are seeking effective solutions to manage joint pain and maintain mobility. Viscosupplementation injections enable patients to remain active and engaged in their desired activities.
With age, the natural lubrication in joints decreases, leading to conditions like osteoarthritis. Viscosupplementation offers a non-surgical solution by replenishing joint fluid, relieving pain, and improving mobility.
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the companys expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163